Part of the Life Sciences Commons

Works by Umamaheswari Natarajan in Life Sciences

2022

Anti-Angiogenesis Effect Associated with Inhibition of VEGFR by F16 Treatment in U87 cell line and Glioblastoma Xenograft Tumors, Umamaheswari Natarajan
Health Professions Division REACH Day

2020

The Emerging Role of GSK-3 Inhibitors as Promising Drug Candidates in NSCLC, Theodore Lemuel Mathuram, Thiagarajan Venkatesan, Umamaheswari Natarajan, Appu Rathinavelu
Health Professions Division REACH Day

Analysis of Epigenetic Modifications in HCC827 and LNCaP cells, Assma Twahir, Maria Da Costa, Umamaheswari Natarajan, Appu Rathinavelu
Health Professions Division REACH Day

3D in Vitro Spheroid: A Preclinical Model for Drug Discovery Against Different Cancer, Jayanta K. Das, Thiagarajan Venkatesan, Umamaheswari Natarajan, Mohammad Algahtani, Theodore L. Mathuram, Priya Dondapati, Appu Rathinavelu
Health Professions Division REACH Day

PD-L1 Expression Due to Epigenetic Modifications During Histone Deacetylase Inhibition in Cancer Cells, Umamaheswari Natarajan, Thiagarajan Venkatesan, Jayanta Kumar Das, Theodore Lemuel Mathuram, Appu Rathinavelu
Health Professions Division REACH Day

Effect of SAHA on the Expression of Chromatin Modifying Enzymes in Prostate and Breast Cancer Cells, Thiagarajan Venkatesan, Umamaheswari Natarajan, Appu Rathinavelu
Health Professions Division REACH Day